Bioequivalence of Eye Drops and Spray Administration of Vigamox

Advanced Ophthalmic Pharma16 enrolled

Overview

The study compares the amounts of Vigamox absorbed when administered as eye drops or in a spray form. Both administrations will be prior to patients undergoing elective cataract surgery and the aqueous samples will be analyzed by a laboratory in a masked fashion. The hypothesis is that there will be no difference between the 2 modes of administration.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

SINGLE

Enrollment

Conditions

Cataract

Interventions

Vigamox - administration in spray formDRUG

Vigamox will be administered in a spray form

Vigamox eye dropsDRUG

Vigamox eye drops

Eligibility

Sex: ALLMin age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients scheduled for elective cataract surgery Exclusion Criteria: * Allergy to Vigamox

Locations (1)

Dept. of Ophthalmology, TAMC

Tel Aviv, Israel

Outcomes

Primary Outcomes

Bioequivalency between the 2 ways of administration

Time frame: 4 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.